{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:05:56Z","timestamp":1781525156269,"version":"3.54.1"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL138628-01A1S1"],"award-info":[{"award-number":["R01 HL138628-01A1S1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 HL144909"],"award-info":[{"award-number":["T32 HL144909"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Sarcoidosis is a T-helper cell mediated disease characterized by granulomatous inflammation. We posited that unsupervised clustering of various features in sarcoidosis would establish phenotypes associated with inflammatory activity measured by 18FDG-PET\/CT. Our goal was to identify unique features capable of distinguishing clusters and subsequently examine the relationship with FDG avidity to substantiate their potential use as markers for sarcoidosis inflammation.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We performed a retrospective study of a diverse, but primarily African American, cohort of 58 subjects with biopsy proven sarcoidosis followed at the University of Illinois Bernie Mac Sarcoidosis Center and Center for Lung Health who underwent 18FDG-PET\/CT scan. Demographic, therapeutic, radiographic, and laboratory data were utilized in unsupervised cluster analysis to identify sarcoidosis phenotypes. The association between clusters, their defining features, and quantitative measurements on 18FDG-PET\/CT was determined. The relevance of these features as markers of 18FDG-PET\/CT inflammatory activity was also investigated.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Clustering determined three distinct phenotypes: (1) a predominantly African American cluster with chronic, quiescent disease, (2) a predominantly African American cluster with elevated conventional inflammatory markers, advanced pulmonary disease and extrathoracic involvement, and (3) a predominantly Caucasian cluster characterized by reduced lymphocyte counts and acute disease. In contrast to the chronic quiescent cluster, Clusters 2 and 3 were defined by significantly greater FDG avidity on 18FDG-PET\/CT. Despite similarly increased inflammatory activity on 18FDG-PET\/CT, Clusters 2, and 3 differed with regards to extrathoracic FDG avidity and circulating lymphocyte profiles, specifically CD4+ T-cells. Notably, absolute lymphocyte counts and CD4+ T-cell counts were found to predict 18FDG-PET\/CT inflammatory activity by receiver operating curve analysis with a 69.2 and 73.42% area under the curve, respectively.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Utilizing cluster analysis, three distinct phenotypes of sarcoidosis were identified with significant variation in race, disease chronicity, and serologic markers of inflammation. These phenotypes displayed varying levels of circulating inflammatory cells. Additionally, reduction in lymphocytes, specifically CD4+ T-cells, was significantly related to activity on 18FDG-PET\/CT. Though future studies are warranted, these findings suggest that peripheral lymphocyte counts may be considered a determinant of sarcoidosis phenotypes and an indicator of active inflammation on 18FDG-PET\/CT.<\/jats:p>","DOI":"10.3389\/fmed.2021.595077","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T04:36:25Z","timestamp":1614141385000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Unsupervised Clustering Reveals Sarcoidosis Phenotypes Marked by a Reduction in Lymphocytes Relate to Increased Inflammatory Activity on 18FDG-PET\/CT"],"prefix":"10.3389","volume":"8","author":[{"given":"Christen","family":"Vagts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Ascoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin R.","family":"Fraidenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Baughman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Edafetanure-Ibeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samreen","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia W.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadera J.","family":"Sweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1513\/AnnalsATS.201511-760OC","article-title":"Sarcoidosis in America. analysis based on health care use","volume":"13","author":"Baughman","year":"2016","journal-title":"Ann Am Thorac Soc."},{"key":"B2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-019-0107-y","article-title":"Sarcoidosis","volume":"5","author":"Grunewald","year":"2019","journal-title":"Nat Rev Dis Primers."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1165\/rcmb.2017-0207OC","article-title":"A circulating microRNA signature serves as a diagnostic and prognostic indicator in sarcoidosis","volume":"58","author":"Ascoli","year":"2018","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1378\/chest.121.4.1239","article-title":"Delayed cutaneous hypersensitivity tests and lymphopenia as activity markers in sarcoidosis","volume":"121","author":"Morell","year":"2002","journal-title":"Chest."},{"key":"B6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.0954-6820.1979.tb13507.x","article-title":"Prognostic significance of lymphopenia in sarcoidosis","volume":"206","author":"Selroos","year":"1979","journal-title":"Acta Med Scand."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e9088","DOI":"10.1371\/journal.pone.0009088","article-title":"Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations","volume":"5","author":"Sweiss","year":"2010","journal-title":"PLoS ONE."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3642832","DOI":"10.1155\/2017\/3642832","article-title":"Local and systemic CD4(+) T Cell exhaustion reverses with clinical resolution of pulmonary sarcoidosis","volume":"2017","author":"Hawkins","year":"2017","journal-title":"J Immunol Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1164\/rccm.201910-1909LE","article-title":"Declining pulmonary function in interstitial lung disease linked to lymphocyte dysfunction","volume":"201","author":"Schott","year":"2020","journal-title":"Am J Respir Crit Care Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"190145","DOI":"10.1183\/16000617.0145-2019","article-title":"Clinical phenotyping: role in treatment decisions in sarcoidosis","volume":"29","author":"Baughman","year":"2020","journal-title":"Eur Respir Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1164\/rccm.200705-742OC","article-title":"Phenotyping sarcoidosis from a pulmonary perspective","volume":"177","author":"Prasse","year":"2008","journal-title":"Am J Respir Crit Care Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1700991","DOI":"10.1183\/13993003.00991-2017","article-title":"Phenotypes of organ involvement in sarcoidosis","volume":"51","author":"Schupp","year":"2018","journal-title":"Eur Respir J."},{"key":"B13","first-page":"19","article-title":"The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.chest.2017.09.026","article-title":"Phenotypic clusters predict outcomes in a longitudinal interstitial lung disease cohort","volume":"153","author":"Adegunsoye","year":"2018","journal-title":"Chest."},{"key":"B15","doi-asserted-by":"publisher","first-page":"43965","DOI":"10.1038\/srep43965","article-title":"Cluster analysis: a new approach for identification of underlying risk factors for coronary artery disease in essential hypertensive patients","volume":"7","author":"Guo","year":"2017","journal-title":"Sci Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1183\/09031936.00123411","article-title":"Two novel, severe asthma phenotypes identified during childhood using a clustering approach","volume":"40","author":"Just","year":"2012","journal-title":"Eur Respir J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaut.2018.11.002","article-title":"Cluster analysis of autoimmune rheumatic diseases based on autoantibodies. new insights for polyautoimmunity","volume":"98","author":"Molano-Gonzalez","year":"2019","journal-title":"J Autoimmun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12890-017-0553-9","article-title":"A cluster analysis of chronic obstructive pulmonary disease in dusty areas cohort identified three subgroups","volume":"17","author":"Kim","year":"2017","journal-title":"BMC Pulm Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejim.2020.04.024","article-title":"Clinical phenotypes and prediction of chronicity in sarcoidosis using cluster analysis in a prospective cohort of 694 patients","volume":"77","author":"Rubio-Rivas","year":"2020","journal-title":"Eur J Intern Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/17476348.2020.1684902","article-title":"Emerging phenotypes of sarcoidosis based on 18F-FDG PET\/CT: a hierarchical cluster analysis","volume":"14","author":"Papiris","year":"2020","journal-title":"Expert Rev Respir Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1055\/s-0034-1376866","article-title":"FDG PET for gauging of sarcoid disease activity","volume":"35","author":"Adams","year":"2014","journal-title":"Semin Respir Crit Care Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/RLU.0000000000001465","article-title":"Suppression of Myocardial 18F-FDG uptake through prolonged high-fat, high-protein, and very-low-carbohydrate diet before FDG-PET\/CT for evaluation of patients with suspected cardiac sarcoidosis","volume":"42","author":"Lu","year":"2017","journal-title":"Clin Nucl Med."},{"key":"B23","first-page":"123","article-title":"18F-FDG PET as a predictor of pulmonary function in sarcoidosis","volume":"28","author":"Keijsers","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3390\/jcm9030890","article-title":"In which patients with sarcoidosis is FDG PET\/CT indicated?","volume":"9","author":"Keijsers","year":"2020","journal-title":"J Clin Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13550-019-0505-x","article-title":"Quantification of pulmonary disease activity in sarcoidosis measured with (18)F-FDG PET\/CT: SUVmax versus total lung glycolysis","volume":"9","author":"Schimmelpennink","year":"2019","journal-title":"EJNMMI Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1823710","DOI":"10.1155\/2018\/1823710","article-title":"The utility of (18)F-FDG PET\/CT for monitoring response and predicting prognosis after glucocorticoids therapy for sarcoidosis","volume":"2018","author":"Chen","year":"2018","journal-title":"Biomed Res Int."},{"key":"B27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4103\/0970-2113.142092","article-title":"Utility of FDG-PET-CT scanning in assessing the extent of disease activity and response to treatment in sarcoidosis","volume":"31","author":"Guleria","year":"2014","journal-title":"Lung India."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1016\/j.rmed.2011.08.012","article-title":"Inflammatory activity assessment by F18 FDG-PET\/CT in persistent symptomatic sarcoidosis","volume":"105","author":"Mostard","year":"2011","journal-title":"Respir Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1080\/1744666X.2016.1196135","article-title":"Biomarkers in sarcoidosis","volume":"12","author":"Chopra","year":"2016","journal-title":"Expert Rev Clin Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. an official american thoracic society clinical practice guideline","volume":"201","author":"Crouser","year":"2020","journal-title":"Am J Respir Crit Care Med."},{"key":"B31","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1158\/0008-5472.CAN-18-0125","article-title":"LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity","volume":"78","author":"Nioche","year":"2018","journal-title":"Cancer Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/os.12102","article-title":"Tumor-to-background ratio to predict response to chemotherapy of osteosarcoma better than standard uptake values","volume":"6","author":"He","year":"2014","journal-title":"Orthop Surg."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3346\/jkms.2017.32.6.1031","article-title":"Correlations between tumor to background ratio on breast-specific gamma imaging and prognostic factors in breast cancer","volume":"32","author":"Lee","year":"2017","journal-title":"J Korean Med Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00259-017-3690-8","article-title":"FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas","volume":"44","author":"Barrington","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2967\/jnumed.114.148056","article-title":"Quantitative PET\/CT scanner performance characterization based upon the society of nuclear medicine and molecular imaging clinical trials network oncology clinical simulator phantom","volume":"56","author":"Sunderland","year":"2015","journal-title":"J Nucl Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1200\/JCO.2016.66.9440","article-title":"Baseline metabolic tumor volume predicts outcome in high-tumor-burden follicular lymphoma: a pooled analysis of three multicenter studies","volume":"34","author":"Meignan","year":"2016","journal-title":"J Clin Oncol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12+<2505::AID-CNCR24>3.0.CO;2-F","article-title":"Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding","volume":"80","author":"Erdi","year":"1997","journal-title":"Cancer."},{"key":"B39","first-page":"5823s","article-title":"Threshold estimation in single photon emission computed tomography and planar imaging for clinical radioimmunotherapy","volume":"55","author":"Erdi","year":"1995","journal-title":"Cancer Res."},{"key":"B40","year":"2018"},{"key":"B41","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10994-016-5575-7","article-title":"A semiparametric method for clustering mixed data","volume":"105","author":"Foss","year":"2016","journal-title":"Machine Learning."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v083.i13","article-title":"kamila: clustering mixed-type data in R and hadoop","volume":"83","author":"Foss","year":"2018","journal-title":"J Statist Software."},{"key":"B43","author":"Hennig","year":"2020","journal-title":"fpc: Flexible Procedures for Clustering"},{"key":"B44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinformatics."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e1916526","DOI":"10.1001\/jamanetworkopen.2019.16526","article-title":"Association of lymphopenia with risk of mortality among adults in the US general population","volume":"2","author":"Zidar","year":"2019","journal-title":"JAMA Netw Open."},{"key":"B46","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0755-4982(06)74709-1","article-title":"[Diagnosis of lymphocytopenia]","volume":"35","author":"Berezn\u00e9","year":"2006","journal-title":"Presse Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.imbio.2014.02.010","article-title":"Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida","volume":"219","author":"Valiathan","year":"2014","journal-title":"Immunobiology."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/e407182008-001","article-title":"HIV infection in the United States household population aged 18-49 years: results from 1999-2006","author":"McQuillan","year":"2008","journal-title":"NCHS Data Brief"},{"key":"B49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2217\/imt.14.103","article-title":"Targeting CD4(+) T cells for the treatment of sarcoidosis: a promising strategy?","volume":"7","author":"Celada","year":"2015","journal-title":"Immunotherapy."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1378\/chest.09-2576","article-title":"The CD4+ lymphopenic sarcoidosis phenotype is highly responsive to anti-tumor necrosis factor-{alpha} therapy","volume":"137","author":"Crouser","year":"2010","journal-title":"Chest."},{"key":"B51","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1164\/rccm.201206-1024OC","article-title":"Perigranuloma localization and abnormal maturation of B cells: emerging key players in sarcoidosis?","volume":"187","author":"Kamphuis","year":"2013","journal-title":"Am J Respir Crit Care Med."},{"key":"B52","first-page":"316","article-title":"Activated CD8+ T cells and natural killer T cells in bronchoalveolar lavage fluid in hypersensitivity pneumonitis and sarcoidosis","volume":"31","author":"T\u00f8ndell","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1002\/eji.201243185","article-title":"Invariant natural killer T (iNKT) cell exhaustion in sarcoidosis","volume":"43","author":"Snyder-Cappione","year":"2013","journal-title":"Eur J Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/MCP.0000000000000498","article-title":"Role of imbalance between Th17 and regulatory T-cells in sarcoidosis","volume":"24","author":"Crouser","year":"2018","journal-title":"Curr Opin Pulm Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.595077\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T04:36:37Z","timestamp":1614141397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.595077\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,24]]},"references-count":54,"alternative-id":["10.3389\/fmed.2021.595077"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.595077","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,24]]},"article-number":"595077"}}